Autophagy in Osteosarcoma

被引:10
|
作者
Nehme, Grace [1 ]
Gordon, Nancy [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA
来源
CURRENT ADVANCES IN THE SCIENCE OF OSTEOSARCOMA: RESEARCH PERSPECTIVES: TUMOR BIOLOGY, ORGAN MICROENVIRONMENT, POTENTIAL NEW THERAPEUTIC TARGETS, AND CANINE MODELS, 2ND EDITION | 2020年 / 1258卷
关键词
Autophagy; Osteosarcoma; Chemotherapy; Survival; Death; PROMOTES DRUG-RESISTANCE; CELL-DEATH; EPIGENETIC CONTROL; DUAL ROLE; CANCER; INHIBITOR; APOPTOSIS; HYDROXYCHLOROQUINE; TEMOZOLOMIDE; ACTIVATION;
D O I
10.1007/978-3-030-43085-6_11
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Osteosarcoma (OS) remains a difficult disease to treat. The standard chemotherapy regimen has not improved survival for the past three decades. Resistance to chemotherapy remains a challenge and constitutes a major concern to clinical investigators. Autophagy has been recognized as a survival mechanism implicated in resistance to chemotherapy. We previously demonstrated chemotherapy to induce autophagy in OS. However, whether induction of autophagy will lead to survival or death has been the focus of many laboratories. Autophagy is a very context-dependent process, and no specific biomarker has been identified to define whether the process will lead to survival or death. In the present chapter, we present some of the mechanisms involved in the process of autophagy and summarize some of the most recent work related to autophagy in OS and the challenges encountered with the use of old and new autophagy inhibitors.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 50 条
  • [21] Licochalcone A Suppresses the Proliferation of Osteosarcoma Cells through Autophagy and ATM-Chk2 Activation
    Shen, Tai-Shan
    Hsu, Yung-Ken
    Huang, Yi-Fu
    Chen, Hsuan-Ying
    Hsieh, Cheng-Pu
    Chen, Chiu-Liang
    MOLECULES, 2019, 24 (13):
  • [22] Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway
    Yue, Ziqi
    Guan, Xin
    Chao, Rui
    Huang, Cancan
    Li, Dongfang
    Yang, Panpan
    Liu, Shanshan
    Hasegawa, Tomoka
    Guo, Jie
    Li, Minqi
    MOLECULES, 2019, 24 (14):
  • [23] Naringenin Induces ROS-Mediated ER Stress, Autophagy, and Apoptosis in Human Osteosarcoma Cell Lines
    Lee, Chiang-Wen
    Huang, Cathy Chia-Yu
    Chi, Miao-Ching
    Lee, Kuan-Han
    Peng, Kuo-Ti
    Fang, Mei-Ling
    Chiang, Yao-Chang
    Liu, Ju-Fang
    MOLECULES, 2022, 27 (02):
  • [24] PERK-mediated Autophagy in Osteosarcoma Cells Resists ER Stress-induced Cell Apoptosis
    Ji, Guang-rong
    Yu, Nai-chun
    Xue, Xiang
    Li, Zong-guang
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2015, 11 (07): : 803 - 812
  • [25] Metformin induces cell cycle arrest, apoptosis and autophagy through ROS/JNK signaling pathway in human osteosarcoma
    Li, Bo
    Zhou, Pingting
    Xu, Kehan
    Chen, Tianrui
    Jiao, Jian
    Wei, Haifeng
    Yang, Xinghai
    Xu, Wei
    Wan, Wei
    Xiao, Jianru
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (01): : 74 - 84
  • [26] Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway
    Li, Zhiquan
    Dong, Hui
    Li, Mo
    Wu, Yaoping
    Liu, Yanwu
    Zhao, Yinan
    Chen, Xiaochao
    Ma, Minliang
    MOLECULAR MEDICINE REPORTS, 2018, 17 (02) : 2719 - 2723
  • [27] Rapamycin-induced autophagy in osteosarcoma cells is mediated via the biglycan/Wnt/b-catenin signaling axis
    Giatagana, Eirini-Maria
    Berdiaki, Aikaterini
    Gaardlos, Margrethe
    Tsatsakis, Aristidis M.
    Samsonov, Sergey A.
    Nikitovic, Dragana
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2022, 323 (06): : C1740 - C1756
  • [28] Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways
    Pang, He
    Wu, Tingrui
    Peng, Zhonghua
    Tan, Qichao
    Peng, Xin
    Zhan, Zeyu
    Song, Lijun
    Wei, Bo
    JOURNAL OF BONE ONCOLOGY, 2022, 33
  • [29] Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment
    Li, Jing
    Yang, Zuozhang
    Li, Yi
    Xia, Junfeng
    Li, Dongqi
    Li, Huiling
    Ren, Mingyan
    Liao, Yedan
    Yu, Shunling
    Chen, Yanjin
    Yang, Yihao
    Zhang, Ya
    ONCOTARGET, 2016, 7 (28) : 44763 - 44778
  • [30] Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
    Mickymaray, Suresh
    Alfaiz, Faiz Abdulaziz
    Paramasivam, Anand
    Veeraraghavan, Vishnu Priya
    Periadurai, Nanthini Devi
    Surapaneni, Krishna Mohan
    Niu, Guangfeng
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (07) : 3641 - 3649